Lipedema pain mystery: could your metabolism be the key?

NCT ID NCT07468097

Recruiting now Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how metabolic markers like insulin resistance and body measurements relate to pain and central sensitization in women with lipedema. Researchers will assess 59 women using questionnaires and physical measurements. The goal is to better understand these connections, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal links between metabolic health and pain in lipedema, pointing toward future management strategies.
What could go wrong: This is a small, observational study with no intervention, so it cannot prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL SENSITIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Lipedema Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CENTRAL SENSITIZATION HOMA-IR LIPEDEMA PAIN

Contacts and locations

Locations

Marmara University Faculty of Medicine Pendik Training and Research Hospital
RECRUITING

Istanbul, Pendik, 34890, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.